Privilège Ventures | Activity

Essay

Quarterly essay covering Xsensio's $7M Series A, AgroSustain's Tornado launch, Cyltronic visit, and Privilège Student Ventures program launch.

Privilège Ventures Insights Q1 2026 - Trust, Resilience, and What Comes Next

Privilège Ventures

privilegeventures.substack.com

Added recently

Milestone

Prof. Dr. Michael Osthoff from University Hospital Basel presented clinical results for AveloMask at ESCMID Global 2026 in Munich, showing 85% detection of dominant LRTI pathogens with 100% specificity across 63 patients.

Avelo

Avelo Privilège Ventures

privilegeventures.substack.com

Added recently

Milestone

Hydromea and Florida Atlantic University awarded USD 1 million through the AUKUS Maritime Innovation Challenge to build an underwater communications network using LUMA optical modems.

Hydromea

Hydromea Privilège Ventures

privilegeventures.substack.com

Added recently

Milestone

Enantios CEO Carin Lightner won third place in the EIC Rising Innovators category (young women innovators under 35) of the 2026 European Prize for Women Innovators.

Enantios

Enantios Privilège Ventures

privilegeventures.substack.com

Added recently

New Fund

Privilège Ventures received approval to consolidate its existing funds into a new open-ended sub-fund structure, enabling continuity of capital, flexible follow-on capacity, and investment decisions driven by company fundamentals rather than fund lifecycle.

Privilège Ventures

Privilège VenturesPrivilège Ventures

privilegeventures.substack.com

Added recently

Investment

Participated in Xsensio's $7M Series A for continuous biochemical monitoring wearables.

Xsensio

Xsensio Privilège Ventures

bioalps.orgMAR 3, 2026 privilegeventures.substack.com

MAR 3, 2026

News

Founder Jacqueline Ruedin Rüsch recognized among Europe's top 100 most influential women in startup and VC for the second consecutive year.

Jacqueline Ruedin Rüsch named Europe's top 100 influential women in VC

Privilège Ventures

bebeez.euMAR 2026

MAR 2026

Investment

Supported Annaida's pre-Series A funding round as EIC Transition beneficiary.

Annaida

Annaida Privilège Ventures

privilege-ventures.comJUL 2025

JUL 2025

Investment

Led Adiposs's CHF 4M Series A for diagnostic imaging and cancer care monitoring.

Adiposs

Adiposs Privilège Ventures

privilege-ventures.comJUN 2025

JUN 2025

Privilège Ventures Activity

Quarterly essay covering Xsensio's $7M Series A, AgroSustain's Tornado launch, Cyltronic visit, and Privilège Student Ventures program launch.

Quarterly essay on fund consolidation, Enantios' EIC prize, Hydromea's AUKUS grant, and Avelo's clinical milestone - articulating the firm's deep tech and health-focused investment philosophy.

Prof. Dr. Michael Osthoff from University Hospital Basel presented clinical results for AveloMask at ESCMID Global 2026 in Munich, showing 85% detection of dominant LRTI pathogens with 100% specificity across 63 patients.

Hydromea and Florida Atlantic University awarded USD 1 million through the AUKUS Maritime Innovation Challenge to build an underwater communications network using LUMA optical modems.

Enantios CEO Carin Lightner won third place in the EIC Rising Innovators category (young women innovators under 35) of the 2026 European Prize for Women Innovators.

Privilège Ventures received approval to consolidate its existing funds into a new open-ended sub-fund structure, enabling continuity of capital, flexible follow-on capacity, and investment decisions driven by company fundamentals rather than fund lifecycle.

Participated in Xsensio's $7M Series A for continuous biochemical monitoring wearables.

Founder Jacqueline Ruedin Rüsch recognized among Europe's top 100 most influential women in startup and VC for the second consecutive year.

Supported Annaida's pre-Series A funding round as EIC Transition beneficiary.

Led Adiposs's CHF 4M Series A for diagnostic imaging and cancer care monitoring.